REMOTE RESULTS OF TREATMENT OF PATIENTS WITH CERVICAL AND OVARIAN CANCER ON THE BACKGROUND OF IMMUNOTHERAPY (40-43)

DOI:

Дата публикации статьи в журнале: 2018/04/16

Название журнала: Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале, Выпуск: 48, Том: 1, Страницы в выпуске: 40-43

Автор: Kamishov S.V.
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent

Автор: Pulatov D.A.
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent

Автор: Yusupova N.B.
, Republican Specilized Scientific and Practical Medical Center of Oncology and Radiology of the Ministry of Health of the Republic of Uzbekistan, Tashkent

Анотация: The aim of the investigation was to study the remote results of treatment of accompanying immunopharmacotherapy in patients with cervical cancer and ovarian cancer. Studies have concluded that the greatest effectiveness in reducing the side effects of chemotherapy in the complex treatment of patients with cervical cancer and ovarian cancer stage II-III, as well as in improving the subjective condition of patients and their quality of life, provides immunotherapy plan, which includes intermittent plasmapheresis followed by extracorporeal immunopharmacotherapy (EIPHT), which reduces the main clinical manifestations of chemotherapy, improve the indicators of the subjective condition of patients and their quality of life. The use of EIFT methods in the treatment of oncogynecological diseases can improve the five-year overall and one-time survival of patients with cervical cancer and ovarian cancer. Developed technique has great potential in cancer practice due to the possibility of eliminating the effects of cancer intoxication, as well as increased own system of antitumor protection of the body, which positively affects the outcome of the disease, as well as improves the quality and life expectancy of the patient.

Ключевые слова: ovarian cancer, cervical cancer,immunotherapy,extracorporeal immunopharmacotherapy,plasmapheresis,polychemotherapy,remote results of treatment,

Данные для цитирования: Kamishov S.V. Pulatov D.A. Yusupova N.B.. REMOTE RESULTS OF TREATMENT OF PATIENTS WITH CERVICAL AND OVARIAN CANCER ON THE BACKGROUND OF IMMUNOTHERAPY (40-43) // Евразийский Союз Ученых — публикация научных статей в ежемесячном научном журнале. Медицинские науки. 2018/04/16; 48(1):40-43.

Скачать в формате PDF

Список литературы: 1. Allarez R. DDR and etoposide (VP16) for the treatment of recurrent or advanced // Clin. Oncol.2005.-V.16.-P.330-337. 2. Bloss J.D., Lucci J.A, Di Saia P.J., et al. A phase II trial of neoadjuvant chemotherapy prior to radical hysterectomy and/or radiation therapy in the management of advanced carcinoma of the uterine cervix // Gynecol. Oncol.- 1995.-Vol .59.-P. 105-110. 3. Boyce J., Fruchter R., Nicastri A. Prognostic factors in the stage I carcinoma of the cervix. // GynecolOncol. - 2011. - 12. - 154-165. 4. Chissov V.I., Starinsky V.V., Petrova G.V. Malignant neoplasms in Russia in 2005 (morbidity and mortality). Moscow, 2007.-With. 246-255. (in Russian language) 5. Davydov M.I., Axel E.M. Statistics of malignant neoplasms in Russia and in the CIS countries in 2008 // Vestnik RONTS im. H.H. Blokhin RAMS. - 2010. - 21 (2) -P 160. (in Russian language) 6. Hernandez, J. R., de la Huerta Sanchez R., Morales Canfield F. Uterine cervix cancer. Clinical stage III. Combined radiotherapychemotherapy treatment. //Gynecol. Obstet. Meh-1999.-vol.59.-P.23 8242. 7. Kharitonova T.V. Cervical cancer: the urgency of the problem, the principles of treatment. // Modern oncology. 2004.-Vol.6.-No.2-P.51-54. (in Russian language) 8. Manko V.M, Petrov R.V., Khaitov R.М. Immunomodulation: history, development trends, current state and prospects. // Immunology. - 2002. - 3 (23). 132-137. (in Russian language) 9. Markman М. maintenance chemotherapy in the management of epithelial ovarian cancer. // cancer metastasis rev. - 2015. - 34 (1). - 11-17. 10. Snezhko T.A., Lysenko I.B., Ushakova N.D. et al. Efficacy of extracorporeal immunotherapy in the complex treatment of patients with relapses and resistant form of hodgkin lymphoma // modern problems of science and education. - 2015. - No. 3. (in Russian language) 11. Zarba J., Jaremtchuk A et al. GETICS a phase l-II study of weekly cisplatin and gemcitabine with concurrent radiotherapy locally advanced cervical cancer. Proc Am Soc Clin Oncol 2001. 20. 206A. 12. Janaga S., Sugiyama T., Hasuo Y., Yakushiji S. Combination therapy of CPT-11 and cisplatin for advanced or recurrent cancer of the cervix.// 10th International Meeting of Gynecological Oncology, 1997.- Caimbra, Portugal, -1997.-P. 153-157.